Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A13571 | Pages: 216 | Charts: 39 | Tables: 111 |
The global thyroid ablation devices market size was valued at $472.79 Million in 2020, and is projected to reach $1,294.43 Million by 2030, registering a CAGR of 10.6%. Growth of the global thyroid ablation devices market is majorly driven by increase in prevalence of thyroid cancer and thyroid nodules; increase in demand of minimally invasive surgeries; and increase in availability of new technologically advanced products for the thyroid ablation. Therefore, these aforementioned factors increase the use of thyroid ablation, which drives the growth of the thyroid ablation devices market. According to the American Cancer Society's (ACS) publications, Cancer Facts & Figures 2021 and Cancer Facts & Figures 2020, an estimated 44,280 adults (12,150 men and 32,130 women) in the U.S. were diagnosed with thyroid cancer.
Get more information on this report : Request Sample Pages
Thyroid cancer is the seventh most common cancer in women. Thus, rise in burden of thyroid cancer is increasing the number of ablation surgeries. In addition, thyroid nodules are also on rise they are quite prevalent among the common diseases of the endocrine system. These aforementioned factors led to surge in usage of thyroid ablation during treatment of thyroid cancer and nodules and are anticipated to drive the growth of the thyroid ablation devices market in the near future. Furthermore, advanced ablation technology is also anticipated to boost the thyroid ablation devices market growth over the forecast period.
[PRODUCTTYPEGRAPH]
Get more information on this report : Request Sample Pages
Thyroid ablation devices are majorly used for the treatment of thyroid cancer, and thyroid nodules. A thyroid nodule is an unusual growth (lump) of thyroid cells in the thyroid gland. Thyroid cancer is a solid tumor cancer that usually shows up as a nodule, or mass, in the thyroid gland, which is located at the front base of your throat. It occurs when rogue cells reproduce too rapidly for the immune system to control. There are several types of thyroid cancer, but two types — papillary thyroid cancer and follicular thyroid cancer — are by far the most common, accounting for some 95 percent of cases.
The ablation technique is used to treat the tumors and nodules minimally invasively to reduce the size of thyroid nodules and restore thyroid function. Radiofrequency Ablation (RFA) is a minimally-invasive technique performed by an endocrine surgeon guided by ultrasound imaging. The physician delivers targeted radio waves that disrupts the nodule’s cells, causing them to shrink as the body absorbs the ablated tissue. RFA also enables patients to resume normal daily activity with minimal recovery time. While surgery may involve removing part of the thyroid, RFA maintains thyroid integrity, which supports improved thyroid function.
Most recently, microwave ablation (MWA) has been proposed to treat thyroid nodules, from the experience of its use in other organs like liver, kidney and lung in particular. MWA advantages respect to RFA includes reduction in treatment time, larger ablation zone, less heat sink effect.
Moreover, laser ablation therapy for benign thyroid nodules is a relatively new, non-surgical procedure. The method has been used previously for treatment of thyroid cysts and for the destruction of lymph nodes with thyroid cancer. This study aimed to determine if laser ablation for benign thyroid nodules was effective, well tolerated. Laser ablation therapy (LAT) is an outpatient procedure used to treat thyroid nodules. Further, High-intensity focused ultrasound (HIFU) is a novel ablation technique that can cause effective shrinkage of thyroid nodules and alleviate pressure symptoms. Its main treatment indication remains benign thyroid nodules.
The presence of key players such as Boston Scientific Corporation, BVM Medical System, Integra LifeSciences, Johnson & Johnson, Medtronic Plc, Medwaves Inc., Olympus Corporation, STARmed Co., Ltd., Terumo Corporation and Theraclion with several initiatives and various technological advanced products is expected to drive the growth in the market.
The COVID-19 outbreak is anticipated to have a negative impact on the global thyroid ablation devices market. All the schedules thyroid nodule ablation surgery and thyroid cancer ablation surgeries were delayed by 3 to 4 weeks as there non-essential surgery. these aforementioned factors are anticipated to drive the thyroid ablation devices market during the forecast period.
However, the high cost the thyroid ablation products and the maintenance cost is expected to hinder the market growth during the forecast period.
The global thyroid ablation devices market is segmented on the basis of type, application, end user, and region. By type, the market is categorized into image-guided ablation, radiofrequency ablation microwave ablation, and others.
On the basis of application, it is divided into thyroid cancer, and thyroid nodules.
On the basis of distribution channel, it is divided into hospitals and clinics, ambulatory surgical centers, cancer specialty centers, and others.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Latin America and Middle East & Africa).
Depending on type, the radiofrequency ablation segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in advancement in new technologies are the key factors for the growth of the segment. Rise in availability of the ablation devices such as RF 3000 Radiofrequency Ablation System, Star radiofrequency electrode fixed for the treatment of thyroid cancer. However, the microwave ablation segment is expected to witness considerable growth during the forecast period, owing to increase in demand of microwave ablation for thyroid tumors and nodules.
[TYPEGRAPH]
Get more information on this report : Request Sample Pages
By application, the thyroid cancer segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in prevalence of thyroid cancer globally. However, thyroid nodules are also anticipated to witness growth as often nodules are observed with the thyroid cancer simukatneously.
On the basis of end user, the hospitals and clinics segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing advanced medical equipment along with specialized medical and technical staff. In addition, bigger hospitals & clinic, offer more specialized treatments and services for patient to admit for overnight stays. Further, many patients prefer to get treatment in a hospital for better results of the surgery.
[APPLICATIONGRAPH]
Get more information on this report : Request Sample Pages
North America garnered a major share in the thyroid ablation devices market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of thyroid cancer, presence of key players, development of the healthcare sector, and presence of new innovative technologies in the region. However, Asia-Pacific is expected to register the highest CAGR of 11.0% from 2021 to 2030, owing to increase in prevalence of thyroid nodules and thyroid cancer, and rising demand of ablation procedure.
The key players operating in the global thyroid ablation devices market include Boston Scientific Corporation, BVM Medical System, Integra LifeSciences, Johnson & Johnson, Medtronic Plc, Medwaves Inc., Olympus Corporation, STARmed Co., Ltd., Terumo Corporation and Theraclion.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
Key Market Segments
CHAPTER 1:INTRODUCTION
1.1.Report description
Key benefits for stakeholders
1.2.Key market segments
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE.
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of thyroid cancer and thyroid nodules
3.5.1.2.Increasing demand for minimally invasive procedures
3.5.1.3.Technological advancements in ablation devices
3.5.2.Restraint
3.5.2.1.High cost of installation and maintenance
3.5.3.Opportunity
3.5.3.1.Increase in healthcare expenditure worldwide
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the thyroid ablation devices market
CHAPTER 4:THYROID ABLATION DEVICES MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Image-guided Ablation
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Radiofrequency Ablation
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Microwave Ablation
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Others
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:THYROID ABLATION DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Thyroid Cancer
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Thyroid Nodules
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:THYROID ABLATION DEVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & Clinics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Ambulatory Surgical Centers
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Cancer Specialty Centers
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
6.5.Others (Cancer research center and R & D companies)
6.5.1.Market size and forecast, by region
6.5.2.Market analysis, by country
CHAPTER 7:THYROID ABLATION DEVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America thyroid ablation devices market, by type
7.2.3.North America thyroid ablation devices market, by application
7.2.4.North America thyroid ablation devices market, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.U.S. thyroid ablation devices market, by type
7.2.5.1.2.U.S. thyroid ablation devices market, by application
7.2.5.1.3.U.S. thyroid ablation devices market, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada thyroid ablation devices market, by type
7.2.5.2.2.Canada thyroid ablation devices market, by application
7.2.5.2.3.Canada thyroid ablation devices market, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico thyroid ablation devices market, by type
7.2.5.3.2.Mexico thyroid ablation devices market, by application
7.2.5.3.3.Mexico thyroid ablation devices market, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe thyroid ablation devices market, by type
7.3.3.Europe thyroid ablation devices market, by application
7.3.4.Europe thyroid ablation devices market, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Germany thyroid ablation devices market, by type
7.3.5.1.2.Germany thyroid ablation devices market, by application
7.3.5.1.3.Germany thyroid ablation devices market, by end user
7.3.5.2.France
7.3.5.2.1.France thyroid ablation devices market, by type
7.3.5.2.2.France thyroid ablation devices market, by application
7.3.5.2.3.France thyroid ablation devices market, by end user
7.3.5.3.UK
7.3.5.3.1.UK thyroid ablation devices market, by type
7.3.5.3.2.UK thyroid ablation devices market, by application
7.3.5.3.3.UK thyroid ablation devices market, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy thyroid ablation devices market, by type
7.3.5.4.2.Italy thyroid ablation devices market, by application
7.3.5.4.3.Italy thyroid ablation devices market, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain thyroid ablation devices market, by type
7.3.5.5.2.Spain thyroid ablation devices market, by application
7.3.5.5.3.Spain thyroid ablation devices market, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe thyroid ablation devices market, by type
7.3.5.6.2.Rest of Europe thyroid ablation devices market, by application
7.3.5.6.3.Rest of Europe thyroid ablation devices market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific thyroid ablation devices market, by type
7.4.3.Asia-Pacific thyroid ablation devices market, by application
7.4.4.Asia-Pacific thyroid ablation devices market, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Japan thyroid ablation devices market, by type
7.4.5.1.2.Japan thyroid ablation devices market, by application
7.4.5.1.3.Japan thyroid ablation devices market, by end user
7.4.5.2.China
7.4.5.2.1.China thyroid ablation devices market, by type
7.4.5.2.2.China thyroid ablation devices market, by application
7.4.5.2.3.China thyroid ablation devices market, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia thyroid ablation devices market, by type
7.4.5.3.2.Australia thyroid ablation devices market, by application
7.4.5.3.3.Australia thyroid ablation devices market, by end user
7.4.5.4.India
7.4.5.4.1.India thyroid ablation devices market, by type
7.4.5.4.2.India thyroid ablation devices market, by application
7.4.5.4.3.India thyroid ablation devices market, by end user
7.4.5.5.South Korea
7.4.5.5.1.South Korea thyroid ablation devices market, by type
7.4.5.5.2.South Korea thyroid ablation devices market, by application
7.4.5.5.3.South Korea thyroid ablation devices market, by end user
7.4.5.6.Rest of Asia-Pacific
7.4.5.6.1.Rest of Asia-Pacific thyroid ablation devices market, by type
7.4.5.6.2.Rest of Asia-Pacific thyroid ablation devices market, by application
7.4.5.6.3.Rest of Asia-Pacific thyroid ablation devices market, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA thyroid ablation devices market, by type
7.5.3.LAMEA thyroid ablation devices market, by application
7.5.4.LAMEA thyroid ablation devices market, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Latin America
7.5.5.1.1.Latin America thyroid ablation devices market, by type
7.5.5.1.2.Latin America thyroid ablation devices market, by application
7.5.5.1.3.Latin America thyroid ablation devices market, by end user
7.5.5.2.Middle East and Africa
7.5.5.2.1.Middle East and Africa thyroid ablation devices market, by type
7.5.5.2.2.Middle East and Africa thyroid ablation devices market, by application
7.5.5.2.3.Middle East and Africa thyroid ablation devices market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.BOSTON SCIENTIFIC CORPORATION
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.BVM MEDICAL SYSTEM
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.INTEGRA LIFE SCIENCES
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.JOHNSON & JOHNSON (ETHICON)
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.MEDTRONIC PLC
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MEDWAVES INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.OLYMPUS CORPORATION
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.STARMED CO.LTD.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Product portfolio
8.9.TERUMO CORPORATION (TERUMO EUROPE)
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.THERACLION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
LIST OF TABLES
TABLE 01.GLOBAL THYROID ABLATION DEVICES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 02.THYROID ABLATION DEVICES MARKET FOR IMAGE-GUIDED ABLATION, BY REGION, 2020–2030 ($MILLION)
TABLE 03.THYROID ABLATION DEVICES MARKET FOR RADIOFREQUENCY ABLATION, BY REGION, 2020–2030 ($MILLION)
TABLE 04.THYROID ABLATION DEVICES MARKET FOR MICROWAVE ABLATION, BY REGION, 2020–2030 ($MILLION)
TABLE 05.THYROID ABLATION DEVICES MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 06.GLOBAL THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 07.THYROID ABLATION DEVICES MARKET FOR THYROID CANCER, BY REGION, 2020–2030 ($MILLION)
TABLE 08.THYROID ABLATION DEVICES MARKET FOR THYROID NODULES , BY REGION, 2020–2030 ($MILLION)
TABLE 09.GLOBAL THYROID ABLATION DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 10.THYROID ABLATION DEVICES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.THYROID ABLATION DEVICES MARKET FOR DRUG STORES & RETAIL PHARMACIES, BY REGION, 2020–2030 ($MILLION)
TABLE 12.THYROID ABLATION DEVICES MARKET FOR CANCER SPECIALTY CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 13.THYROID ABLATION DEVICES MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.GLOBAL THYROID ABLATION DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 19.U.S. THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 20.U.S. THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 21.U.S. THYROID ABLATION DEVICES MARKET, BY DISTRIBUTIO CHANNEL, 2020-2030 ($MILLION)
TABLE 22.CANADA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 23.CANADA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 24.CANADA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.MEXICO THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 26.MEXICO THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 27.MEXICO THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28.EUROPE THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 29.EUROPE THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 30.EUROPE THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.EUROPE THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.GERMANY THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 33.GERMANY THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 34.GERMANY THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.FRANCE THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 36.FRANCE THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 37.FRANCE THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.UK THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 39.UK THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 40.UK THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.ITALY THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 42.ITALY THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 43.ITALY THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.SPAIN THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 45.SPAIN THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 46.SPAIN THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47.REST OF EUROPE THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 48.REST OF EUROPE THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 49.REST OF EUROPE THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 54.JAPAN THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 55.JAPAN THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 56.JAPAN THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.CHINA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 58.CHINA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 59.CHINA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.AUSTRALIA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 61.AUSTRALIA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 62.AUSTRALIA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.INDIA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 64.INDIA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 65.SOUTH KOREA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 66.INDIA THYROID ABLATION DEVICES MARKET, END USER, 2020-2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70.LAMEA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 71.LAMEA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 72.LAMEA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73.LAMEA THYROID ABLATION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 74.LATIN AMERICA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 75.LATIN AMERICA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 76.LATIN AMERICA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 77.MIDDLE EAST AND AFRICA THYROID ABLATION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 78.MIDDLE EAST AND AFRICA THYROID ABLATION DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 79.MIDDLE EAST AND AFRICA THYROID ABLATION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 80.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 81.BOSTON SCIENTIFIC : OPERATING SEGMENTS
TABLE 82.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 83.BVM: COMPANY SNAPSHOT
TABLE 84.BVM: OPERATING SEGMENTS
TABLE 85.BVM: PRODUCT PORTFOLIO
TABLE 86.BVM: KEY DEVELOPMENTS
TABLE 87.INTEGRA: COMPANY SNAPSHOT
TABLE 88.INTEGRA: PRODUCT SEGMENTS
TABLE 89.INTEGRA: PRODUCT PORTFOLIO
TABLE 90.J & J: COMPANY SNAPSHOT
TABLE 91.J & J: OPERATING BUSINESS SEGMENT
TABLE 92.J & J: PRODUCT PORTFOLIO
TABLE 93.J & J: KEY DEVELOPMENTS
TABLE 94.MEDTRONIC: COMPANY SNAPSHOT
TABLE 95.MEDTRONIC: PRODUCT SEGMENTS
TABLE 96.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 97.MEDTRONIC: KEY DEVELOPMENTS
TABLE 98.MEDWAVES: COMPANY SNAPSHOT
TABLE 99.MEDWAVES: PRODUCT PORTFOLIO
TABLE 100.OLYMPUS: COMPANY SNAPSHOT
TABLE 101.OLYMPUS: PRODUCT SEGMENTS
TABLE 102.OLYMPUS: PRODUCT PORTFOLIO
TABLE 103.STARMED: COMPANY SNAPSHOT
TABLE 104.STARMED: PRODUCT PORTFOLIO
TABLE 105.TERUMO: COMPANY SNAPSHOT
TABLE 106.TERUMO: OPERATING BUSINESS SEGMENTS
TABLE 107.TERUMO: PRODUCT PORTFOLIO
TABLE 108.TERUMO: KEY DEVELOPMENTS
TABLE 109.THERACLION: COMPANY SNAPSHOT
TABLE 110.THERACLION: OPERATING SEGMENTS
TABLE 111.THERACLION: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.THYROID ABLATION DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2020–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2020–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR IMAGE-GUIDED ABLATION, BY COUNTRY, 2020–2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR RADIOFREQUENCY ABLATION, BY COUNTRY, 2020–2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR BARBITURATE, BY COUNTRY, 2020–2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2020–2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR THYROID CANCER, BY COUNTRY, 2020–2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR STROKE, BY COUNTRY, 2020–2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTER, BY COUNTRY, 2020–2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR CANCER SPECIALTY CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF THYROID ABLATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2020–2030 (%)
FIGURE 23.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 26.INTEGRA: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.INTEGRA: REVENUE SHARE BY REGION, 2020(%)
FIGURE 29.J & J: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.J & J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.J & J: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.MEDTRONIC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 35.OLYMPUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.OLYMPUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.OLYMPUS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 38.TERUMO: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.TERUMO: REVENUE SHARE BY SEGMENT, 2020 (%)